4.6 Article

The effects of coagulation factors and their inhibitors on proliferation and migration in colorectal cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Mismatch Repair-Deficient Colorectal Cancer: Building on Checkpoint Blockade

Zhaohui Jin et al.

Summary: Immunotherapy with immune checkpoint inhibitors (ICIs) has transformed the treatment of colorectal cancer (CRC) with deficient DNA mismatch repair (dMMR) by producing frequent and durable responses. However, resistance mechanisms and biomarkers to identify resistant patients are still needed. Understanding these mechanisms may lead to the development of novel strategies to overcome resistance and broaden the benefit of ICIs.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban

Yu-Sheng Lin et al.

Summary: Dabigatran may be associated with a lower risk of cancer-related death and all-cause mortality compared with rivaroxaban, as well as lower risks of major bleeding and GI bleeding.

CANCER MEDICINE (2021)

Article Hematology

Longitudinal Dynamics of Coagulation and Angiogenesis Markers in Cancer Patients During and After Chemotherapy

Elina A. Beleva et al.

Summary: This study revealed that MPTF increased significantly after treatment cessation, while TF-Ag and ANG-2 decreased throughout active treatment and dropped significantly 3 months post therapy cessation. The disease prognosis of patients was closely associated with pre-chemotherapy levels of TF-Ag and fibrinogen.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

Article Immunology

Myeloid cell-synthesized coagulation factor X dampens antitumor immunity

Claudine Graf et al.

SCIENCE IMMUNOLOGY (2019)

Article Biology

Evaluation of colorectal cancer subtypes and cell lines using deep learning

Jonathan Ronen et al.

LIFE SCIENCE ALLIANCE (2019)

Meeting Abstract Hematology

Microparticle-mediated transfer of TF hypercoagulability between cancer cells

H. Shaker et al.

THROMBOSIS RESEARCH (2016)

Article Medicine, General & Internal

Incidence of venous thromboembolism in patients hospitalized with cancer

PD Stein et al.

AMERICAN JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

JW Blom et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Review Hematology

A cell-based model of hemostasis

M Hoffman et al.

THROMBOSIS AND HAEMOSTASIS (2001)

Article Biochemistry & Molecular Biology

Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the αvβ5 integrin

SC Even-Ram et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Multidisciplinary Sciences

Thrombin signalling and protease-activated receptors

SR Coughlin

NATURE (2000)